More Chimeric Therapeutics Limited news Chimeric Therapeutics LimitedASX: CHM CHM CORE NK Combination Phase 1b trial update Nov 13, 2025 at 4:42 AM UTC As issuedPlain English Chimeric Therapeutics Ltd has released a press release. View Attachment
